CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 80 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $3,560,762 | +47.7% | 150,752 | -6.8% | 0.00% | +50.0% |
Q3 2023 | $2,410,425 | +27.9% | 161,665 | -6.0% | 0.00% | 0.0% |
Q2 2023 | $1,884,024 | +228.6% | 172,057 | +161.7% | 0.00% | +100.0% |
Q1 2023 | $573,305 | +258.3% | 65,746 | +86.4% | 0.00% | – |
Q1 2021 | $160,000 | -29.2% | 35,269 | -10.6% | 0.00% | – |
Q4 2020 | $226,000 | -86.8% | 39,466 | -91.9% | 0.00% | -100.0% |
Q2 2020 | $1,711,000 | +88.6% | 490,223 | -19.9% | 0.00% | 0.0% |
Q1 2020 | $907,000 | +1195.7% | 612,290 | +1624.3% | 0.00% | – |
Q4 2019 | $70,000 | -70.6% | 35,509 | -23.8% | 0.00% | – |
Q3 2019 | $238,000 | -23.5% | 46,594 | +6.9% | 0.00% | – |
Q2 2019 | $311,000 | -97.2% | 43,589 | -94.7% | 0.00% | -100.0% |
Q1 2019 | $11,024,000 | +3355.8% | 830,107 | +1949.0% | 0.01% | – |
Q4 2018 | $319,000 | -29.6% | 40,513 | -1.1% | 0.00% | – |
Q3 2018 | $453,000 | -41.9% | 40,943 | -29.6% | 0.00% | -100.0% |
Q2 2018 | $780,000 | +179.6% | 58,152 | +170.6% | 0.00% | – |
Q1 2018 | $279,000 | +3.0% | 21,489 | -27.0% | 0.00% | – |
Q4 2017 | $271,000 | +113.4% | 29,435 | +85.8% | 0.00% | – |
Q3 2017 | $127,000 | – | 15,842 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |